Mechanotransduction in Androgenetic Alopecia: An In Silico Repositioning Study of PIEZO1 and MLCK Axis Using Cofolding and Pilosebaceous Single-Cell Atlas Constraints
April 2026
in “
Zenodo (CERN European Organization for Nuclear Research)
”
TLDR Potential compounds may inhibit hair loss by targeting a non-androgen pathway.
A recent study explores a non-androgen pathway for treating androgenetic alopecia (AGA), focusing on the PIEZO1 mechanosensation and myosin-light-chain kinase (MLCK) axis, which contributes to follicular miniaturization. The study screened a library of 2,529 natural compounds using advanced computational methods to identify candidates that target this pathway. The findings suggest potential compounds with high topical bioavailability that could inhibit MLCK, similar to ML-7, which has shown promise in restoring hair growth in models. However, these results are based on in silico analysis and require further in vitro validation before any clinical applications can be considered.
